MDT

99.62

1.62% -1.64

Handel nachbörslich: 101.00 1.38 +1.39%

Medtronic Plc (MDT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$101.26

Offen:

$101.43

24-Stunden-Volumen:

4.65M

Relative Volume:

0.67

Marktkapitalisierung:

$127.71B

Einnahmen:

$34.76B

Nettoeinkommen (Verlust:

$4.79B

KGV:

26.91

EPS:

3.7017

Netto-Cashflow:

$5.21B

1W Leistung:

-2.36%

1M Leistung:

+8.05%

6M Leistung:

+13.92%

1J Leistung:

+18.65%

1-Tages-Spanne:

$99.58

$102.00

1-Wochen-Bereich:

$99.58

$102.91

52-Wochen-Spanne:

$79.29

$106.33

Medtronic Plc Stock (MDT) Company Profile

Firmenname

Medtronic Plc

Sektor

Healthcare (1131)

Branche

Medical Devices (143)

Telefon

01135314381700

Adresse

BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY

Mitarbeiter

95,000

Twitter

@Medtronic

Nächster Verdiensttermin

2025-08-19

Neueste SEC-Einreichungen

MDT's Discussions on Twitter

Vergleichen Sie MDT mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MDT Medtronic Plc	99.62	129.82B	34.76B	4.79B	5.21B	3.7017
ABT Abbott Laboratories	121.25	212.30B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	92.53	139.11B	19.35B	2.78B	3.82B	1.8696
SYK Stryker Corp	349.23	135.23B	24.38B	2.94B	4.07B	7.6159
EW Edwards Lifesciences Corp	83.28	48.93B	5.88B	1.34B	799.60M	2.3489

Medtronic Plc Stock (MDT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-11-19	Hochstufung	Goldman	Sell → Neutral
2025-06-30	Hochstufung	Wolfe Research	Underperform → Peer Perform
2025-06-16	Eingeleitet	Leerink Partners	Outperform
2025-03-04	Hochstufung	Citigroup	Neutral → Buy
2024-10-10	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2024-08-21	Bestätigt	Oppenheimer	Perform
2024-08-15	Hochstufung	UBS	Sell → Neutral
2024-08-14	Herabstufung	Stifel	Buy → Hold
2024-05-30	Eingeleitet	Goldman	Sell
2023-07-19	Eingeleitet	Robert W. Baird	Neutral
2023-06-30	Eingeleitet	CL King	Buy
2023-05-30	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2023-04-24	Hochstufung	Wells Fargo	Equal Weight → Overweight
2023-03-29	Herabstufung	UBS	Buy → Sell
2023-01-09	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2022-11-23	Herabstufung	Citigroup	Buy → Neutral
2022-11-23	Herabstufung	Oppenheimer	Outperform → Perform
2022-11-16	Herabstufung	Deutsche Bank	Buy → Hold
2022-10-18	Eingeleitet	Barclays	Equal Weight
2022-10-13	Eingeleitet	Mizuho	Buy
2022-10-12	Eingeleitet	Jefferies	Hold
2022-08-24	Herabstufung	Raymond James	Outperform → Mkt Perform
2022-07-06	Eingeleitet	Wolfe Research	Underperform
2022-06-01	Herabstufung	Atlantic Equities	Overweight → Neutral
2022-05-27	Herabstufung	Needham	Buy → Hold
2022-04-13	Herabstufung	Truist	Buy → Hold
2022-03-02	Fortgesetzt	BofA Securities	Buy
2022-01-10	Herabstufung	BTIG Research	Buy → Neutral
2022-01-07	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2022-01-04	Herabstufung	Piper Sandler	Overweight → Neutral
2021-12-17	Herabstufung	JP Morgan	Overweight → Neutral
2021-12-16	Herabstufung	Wells Fargo	Overweight → Equal Weight
2021-12-10	Eingeleitet	RBC Capital Mkts	Outperform
2021-06-10	Fortgesetzt	Cowen	Outperform
2021-05-25	Eingeleitet	Barclays	Equal Weight
2021-04-15	Eingeleitet	Atlantic Equities	Overweight
2020-12-15	Hochstufung	Goldman	Sell → Neutral
2020-12-15	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-10-08	Hochstufung	Bernstein	Mkt Perform → Outperform
2020-10-08	Hochstufung	Stifel	Hold → Buy
2020-09-11	Eingeleitet	Wolfe Research	Peer Perform
2020-05-14	Herabstufung	DZ Bank	Buy → Hold
2020-03-30	Herabstufung	Needham	Strong Buy → Buy
2020-03-25	Hochstufung	DZ Bank	Hold → Buy
2020-03-05	Eingeleitet	Citigroup	Buy
2020-02-13	Eingeleitet	Goldman	Sell
2020-01-08	Eingeleitet	SunTrust	Buy
2020-01-02	Hochstufung	Guggenheim	Neutral → Buy
2019-06-05	Hochstufung	Wells Fargo	Market Perform → Outperform
2019-02-04	Bestätigt	Needham	Strong Buy
2019-01-03	Eingeleitet	Deutsche Bank	Buy
2019-01-02	Herabstufung	Citigroup	Buy → Neutral
2018-12-19	Hochstufung	JP Morgan	Neutral → Overweight
2018-11-28	Eingeleitet	UBS	Buy
2018-10-16	Eingeleitet	Barclays	Overweight
2018-08-27	Bestätigt	Argus	Buy

Alle ansehen

Medtronic Plc Aktie (MDT) Neueste Nachrichten

Dec 09, 2025

CU & Medtronic Launch Strategic Research Partnership to Drive Breakthroughs in AI, Robotics and Sustainability - CU Anschutz newsroom

Dec 09, 2025

Medtronic: This Dividend Aristocrat Is Just Getting Started (NYSE:MDT) - Seeking Alpha

Dec 09, 2025

Medtronic changes investor relations leadership ahead of diabetes spinout - MedTech Dive

Dec 09, 2025

The Year Medtronic Set an Example for Supply Chain Optimization - Medical Device and Diagnostic industry

Dec 08, 2025

Medtronic has a new head of investor relations, former head to join Diabetes spin-off MiniMed - MassDevice

Dec 08, 2025

Medtronic’s Hugo robotic system gets FDA nod - BioWorld MedTech

Dec 08, 2025

SVB Wealth LLC Sells 22,762 Shares of Medtronic PLC $MDT - MarketBeat

Dec 08, 2025

Thematics Asset Management Sells 13,298 Shares of Medtronic PLC $MDT - MarketBeat

Dec 08, 2025

Orchestra BioMed and Medtronic Leadership to Present on Strategic Collaboration for AVIM Therapy at 2025 Innovation in Cardiology Intervention Meeting - Quiver Quantitative

Dec 08, 2025

Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting - The Manila Times

Dec 08, 2025